α-Blocker Monotherapy and α-Blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years' Long-Term Results

PURPOSE: We compared the effects of alpha-adrenergic receptor blocker (α-blocker) monotherapy with those of combination therapy with α-blocker and 5-alpha-reductase inhibitor (5-ARI) on benign prostatic hyperplasia (BPH) progression for over 10 years. MATERIALS AND METHODS: A total of 620 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Teak Jun, Kim, Chun Il, Park, Choal Hee, Kim, Byung Hoon, Kwon, Young Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332135/
https://www.ncbi.nlm.nih.gov/pubmed/22536467
http://dx.doi.org/10.4111/kju.2012.53.4.248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332135/
https://www.ncbi.nlm.nih.gov/pubmed/22536467
http://dx.doi.org/10.4111/kju.2012.53.4.248

Ejemplares similares